Bacterial	O
lipopolysaccharide	O
activates	O
nuclear	B-protein
factor-kappaB	I-protein
through	O
interleukin-1	B-protein
signaling	I-protein
mediators	I-protein
in	O
cultured	B-cell_line
human	I-cell_line
dermal	I-cell_line
endothelial	I-cell_line
cells	I-cell_line
and	O
mononuclear	B-cell_type
phagocytes	I-cell_type
.	O

Bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-mediated	O
immune	O
responses	O
,	O
including	O
activation	O
of	O
monocytes	B-cell_type
,	O
macrophages	B-cell_type
,	O
and	O
endothelial	B-cell_type
cells	I-cell_type
,	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
Gram-negative	O
bacteria-induced	O
sepsis	O
syndrome	O
.	O

Activation	O
of	O
NF-kappaB	B-protein
is	O
thought	O
to	O
be	O
required	O
for	O
cytokine	O
release	O
from	O
LPS-responsive	B-cell_type
cells	I-cell_type
,	O
a	O
critical	O
step	O
for	O
endotoxic	O
effects	O
.	O

Here	O
we	O
investigated	O
the	O
role	O
and	O
involvement	O
of	O
interleukin-1	B-protein
(	O
IL-1	B-protein
)	O
and	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	O
TNF-alpha	B-protein
)	O
signal	B-protein
transducer	I-protein
molecules	I-protein
in	O
LPS	O
signaling	O
in	O
human	B-cell_type
dermal	I-cell_type
microvessel	I-cell_type
endothelial	I-cell_type
cells	I-cell_type
(	O
HDMEC	B-cell_type
)	O
and	O
THP-1	B-cell_line
monocytic	I-cell_line
cells	I-cell_line
.	O

LPS	O
stimulation	O
of	O
HDMEC	B-cell_type
and	O
THP-1	B-cell_line
cells	I-cell_line
initiated	O
an	O
IL-1	B-protein
receptor	I-protein
-like	O
NF-kappaB	B-protein
signaling	O
cascade	O
.	O

In	O
transient	O
cotransfection	O
experiments	O
,	O
dominant	O
negative	O
mutants	O
of	O
the	O
IL-1	B-protein
signaling	O
pathway	O
,	O
including	O
MyD88	B-protein
,	O
IRAK	B-protein
,	O
IRAK2	B-protein
,	O
and	O
TRAF6	B-protein
inhibited	O
both	O
IL-1	B-protein
-and	O
LPS-induced	O
NF-kappaB	B-protein
-luciferase	B-protein
activity	O
.	O

LPS-induced	O
NF-kappaB	B-protein
activation	O
was	O
not	O
inhibited	O
by	O
a	O
dominant	O
negative	O
mutant	O
of	O
TRAF2	B-protein
that	O
is	O
involved	O
in	O
TNF	B-protein
signaling	O
.	O

LPS-induced	O
activation	O
of	O
NF-kappaB-responsive	B-DNA
reporter	I-DNA
gene	I-DNA
was	O
not	O
inhibited	O
by	O
IL-1	B-protein
receptor	O
antagonist	O
.	O

TLR2	B-protein
and	O
TLR4	B-protein
were	O
expressed	O
on	O
the	O
cell	O
surface	O
of	O
HDMEC	B-cell_type
and	O
THP-1	B-cell_line
cells	I-cell_line
.	O

These	O
findings	O
suggest	O
that	O
a	O
signal	B-protein
transduction	I-protein
molecule	I-protein
in	O
the	O
LPS	O
receptor	O
complex	O
may	O
belong	O
to	O
the	O
IL-1	B-protein
receptor/toll-like	O
receptor	O
(	O
TLR	O
)	O
super	O
family	O
,	O
and	O
the	O
LPS	O
signaling	O
cascade	O
uses	O
an	O
analogous	O
molecular	O
framework	O
for	O
signaling	O
as	O
IL-1	B-protein
in	O
mononuclear	B-cell_type
phagocytes	I-cell_type
and	O
endothelial	B-cell_type
cells	I-cell_type
.	O

Communication	NULL
Bacterial	NULL
Lipopolysaccharide	NULL
Activates	NULL
Nuclear	NULL
Factor-KB	NULL
through	NULL
Interleukin-1	NULL
Signaling	NULL
Mediators	NULL
in	NULL
Cultured	NULL
Human	NULL
Dermal	NULL
Endothelial	NULL
Cells	NULL
and	NULL
Mononuclear	NULL
Phagocytes*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
21	NULL
,	NULL
1999	NULL
)	NULL
Frank	NULL
X	NULL
.	NULL

Zhang	NULL
?	NULL

,	NULL
Carsten	NULL
J.	NULL
Kirschning§	NULL
,	NULL
Roberta	NULL
Mancinelli1	NULL
,	NULL
Xiao-Ping	NULL
Xu|	NULL
,	NULL
Yiping	NULL
Jing	NULL
,	NULL
Emmanuelle	NULL
Faure	NULL
}	NULL
,	NULL
Alberto	NULL
Mantovani1	NULL
,	NULL
Mike	NULL
Rothe§	NULL
,	NULL
Marta	NULL
Muzio	NULL
,	NULL
and	NULL
Moshe	NULL
Arditi	NULL
}	NULL
#	NULL
**	NULL
From	NULL
the	NULL
{	NULL
Division	NULL
of	NULL
Pediatric	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Ahmanson	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Steven	NULL
Spielberg	NULL
Pediatric	NULL
Research	NULL
Center	NULL
and	NULL
the	NULL
|\Division	NULL
of	NULL
Cardiology	NULL
and	NULL
the	NULL
Burns	NULL
and	NULL
Allen	NULL
Research	NULL
Institute	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
and	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
California	NULL
90048	NULL
,	NULL
§Tularik	NULL
Inc.	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
98080	NULL
,	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Immunology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Mario	NULL
Negri	NULL
Institute	NULL
,	NULL
1-20157	NULL
Milan	NULL
,	NULL
Italy	NULL
Bacterial	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-mediated	NULL
immune	NULL
responses	NULL
,	NULL
including	NULL
activation	NULL
of	NULL
monocytes	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
,	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
Gram-negative	NULL
bacteria-induced	NULL
sepsis	NULL
syndrome	NULL
.	NULL

Activation	NULL
of	NULL
NF-KB	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
required	NULL
for	NULL
cytokine	NULL
release	NULL
from	NULL
LPS-responsive	NULL
cells	NULL
,	NULL
a	NULL
critical	NULL
step	NULL
for	NULL
endotoxic	NULL
effects	NULL
.	NULL

Here	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
and	NULL
involvement	NULL
of	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF-a	NULL
)	NULL
signal	NULL
transducer	NULL
molecules	NULL
in	NULL
LPS	NULL
signaling	NULL
in	NULL
human	NULL
dermal	NULL
microvessel	NULL
endothelial	NULL
cells	NULL
(	NULL
HDMEC	NULL
)	NULL
and	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
HDMEC	NULL
and	NULL
THP	NULL
-1	NULL
cells	NULL
initiated	NULL
an	NULL
IL-1	NULL
receptor-like	NULL
NF-KB	NULL
signaling	NULL
cascade	NULL
.	NULL

In	NULL
transient	NULL
cotransfection	NULL
experiments	NULL
,	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
the	NULL
IL-1	NULL
signaling	NULL
pathway	NULL
,	NULL
including	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
IRAK2	NULL
,	NULL
and	NULL
TRAF6	NULL
inhibited	NULL
both	NULL
IL-1-and	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B-luciferase	NULL
activity	NULL
.	NULL

LPS-induced	NULL
NF-KB	NULL
activation	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
TRAF2	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
TNF	NULL
sig-naling	NULL
.	NULL

LPS-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B-responsive	NULL
reporter	NULL
gene	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
IL-1	NULL
receptor	NULL
antago-nist	NULL
.	NULL

TLR2	NULL
and	NULL
TLR4	NULL
were	NULL
expressed	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
HDMEC	NULL
and	NULL
THP	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
a	NULL
signal	NULL
transduction	NULL
molecule	NULL
in	NULL
the	NULL
LPS	NULL
receptor	NULL
complex	NULL
may	NULL
belong	NULL
to	NULL
the	NULL
IL-1	NULL
receptor/toll-like	NULL
receptor	NULL
(	NULL
TLR	NULL
)	NULL
super	NULL
family	NULL
,	NULL
and	NULL
the	NULL
LPS	NULL
signaling	NULL
cascade	NULL
uses	NULL
an	NULL
analogous	NULL
molecular	NULL
framework	NULL
for	NULL
signaling	NULL
as	NULL
IL-1	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
and	NULL
endothelial	NULL
cells	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
Al40275	NULL
(	NULL
to	NULL
M	NULL
.	NULL

A	NULL
.	NULL
)	NULL

,	NULL
by	NULL
funds	NULL
from	NULL
MURST	NULL
and	NULL
AIRC	NULL
,	NULL
and	NULL
European	NULL
Community	NULL
Grants	NULL
BIO4CT972107	NULL
and	NULL
BMH4CT983277	NULL
(	NULL
to	NULL
M.	NULL
M	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Pediatrics	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
8700	NULL
Beverly	NULL
Blvd	NULL
.	NULL

,	NULL
Rm	NULL
.	NULL

4310	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90048	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
310-855-4471	NULL
;	NULL
Fax	NULL
:	NULL
310-652-0681	NULL
;	NULL
E-mail	NULL
:	NULL
moshe.arditi	NULL
@	NULL
eshs.org	NULL
.	NULL

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

12	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
19	NULL
,	NULL
pp	NULL
.	NULL

7611-7614	NULL
,	NULL
1999	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc	NULL
.	NULL

Printed	NULL
in	NULL
U.S.A.	NULL
Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
or	NULL
endotoxin	NULL
,	NULL
is	NULL
the	NULL
major	NULL
component	NULL
of	NULL
the	NULL
outer	NULL
surface	NULL
of	NULL
Gram-negative	NULL
bacteria	NULL
.	NULL

LPS	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
and	NULL
inflammatory	NULL
systems	NULL
,	NULL
including	NULL
macrophages	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
contributes	NULL
to	NULL
systemic	NULL
changes	NULL
known	NULL
as	NULL
septic	NULL
shock	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

LPS-induced	NULL
activation	NULL
of	NULL
monocytes/macrophages	NULL
is	NULL
mediated	NULL
through	NULL
a	NULL
cell	NULL
surface	NULL
receptor	NULL
glycoprotein	NULL
,	NULL
known	NULL
as	NULL
membrane	NULL
CD14	NULL
(	NULL
mCD14	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
LPS	NULL
to	NULL
mCD14	NULL
is	NULL
enhanced	NULL
by	NULL
LPS-binding	NULL
protein	NULL
,	NULL
a	NULL
plasma	NULL
protein	NULL
(	NULL
3	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
vascular	NULL
endothelial	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
mCD14	NULL
and	NULL
respond	NULL
to	NULL
LPS	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
soluble	NULL
CD14	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

We	NULL
(	NULL
7	NULL
)	NULL
and	NULL
others	NULL
(	NULL
8-12	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
ERK1	NULL
,	NULL
ERK2	NULL
,	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
,	NULL
and	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
appear	NULL
to	NULL
be	NULL
important	NULL
for	NULL
LPS-induced	NULL
cellular	NULL
activation	NULL
.	NULL

LPS	NULL
rapidly	NULL
induces	NULL
nuclear	NULL
factor-	NULL
«	NULL
kB	NULL
(	NULL
NF-kB	NULL
)	NULL
in	NULL
both	NULL
monocytic	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
and	NULL
endothelial	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-KB	NULL
is	NULL
required	NULL
for	NULL
release	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
including	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
the	NULL
signaling	NULL
cascade	NULL
induced	NULL
by	NULL
LPS	NULL
to	NULL
activate	NULL
NF-kB	NULL
are	NULL
un-known	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
signaling	NULL
LPS	NULL
receptor	NULL
is	NULL
still	NULL
unidentified	NULL
.	NULL

The	NULL
toll	NULL
gene	NULL
controls	NULL
dorsoventral	NULL
pattern	NULL
formation	NULL
during	NULL
the	NULL
early	NULL
embryonic	NULL
development	NULL
of	NULL
Drosophila	NULL
melanogaster	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Toll	NULL
initiates	NULL
a	NULL
signaling	NULL
pathway	NULL
homologous	NULL
to	NULL
the	NULL
mammalian	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
cascade	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
toll	NULL
family	NULL
of	NULL
receptors	NULL
is	NULL
defined	NULL
by	NULL
homology	NULL
to	NULL
the	NULL
Drosophila	NULL
toll	NULL
protein	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
mammalian	NULL
IL-1	NULL
receptor	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
toll	NULL
family	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Five	NULL
other	NULL
mammalian	NULL
family	NULL
members	NULL
(	NULL
toll-like	NULL
receptors	NULL
1	NULL
through	NULL
5	NULL
,	NULL
TLR1-5	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
but	NULL
their	NULL
function	NULL
is	NULL
uncertain	NULL
.	NULL

Several	NULL
TLRs	NULL
,	NULL
similar	NULL
to	NULL
IL-1R	NULL
,	NULL
have	NULL
been	NULL
observed	NULL
to	NULL
signal	NULL
through	NULL
the	NULL
NF-kB	NULL
pathway	NULL
(	NULL
19-22	NULL
)	NULL
.	NULL

LPS	NULL
signaling	NULL
also	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
and	NULL
recent	NULL
studies	NULL
suggested	NULL
that	NULL
a	NULL
toll-like	NULL
receptor	NULL
(	NULL
TLR	NULL
)	NULL
might	NULL
be	NULL
a	NULL
signaling	NULL
receptor	NULL
that	NULL
is	NULL
activated	NULL
by	NULL
LPS	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
these	NULL
reports	NULL
,	NULL
expression	NULL
of	NULL
TLR2	NULL
in	NULL
LPS-unresponsive	NULL
human	NULL
embryonic	NULL
kidney	NULL
cells	NULL
(	NULL
293	NULL
cells	NULL
)	NULL
enabled	NULL
these	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
LPS	NULL
stimulation	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

These	NULL
investigators	NULL
observed	NULL
that	NULL
LPS	NULL
binds	NULL
to	NULL
a	NULL
TLR2	NULL
extracellular	NULL
domain	NULL
and	NULL
suggested	NULL
that	NULL
TLR2	NULL
is	NULL
a	NULL
candidate	NULL
for	NULL
a	NULL
long	NULL
sought	NULL
LPS	NULL
receptor	NULL
,	NULL
although	NULL
the	NULL
data	NULL
were	NULL
generated	NULL
from	NULL
a	NULL
transfected	NULL
and	NULL
normally	NULL
LPS-unresponsive	NULL
cell	NULL
line	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
in	NULL
the	NULL
LPS-resistant	NULL
C3H-HeJ	NULL
mice	NULL
has	NULL
implicated	NULL
another	NULL
toll	NULL
homologue	NULL
(	NULL
TLR4	NULL
)	NULL
as	NULL
a	NULL
signal-transducing	NULL
component	NULL
in	NULL
the	NULL
LPS	NULL
receptor	NULL
complex	NULL
(	NULL
24	NULL
)	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
the	NULL
IL-1	NULL
signaling	NULL
pathway	NULL
in	NULL
mammals	NULL
is	NULL
strikingly	NULL
similar	NULL
to	NULL
the	NULL
toll	NULL
signaling	NULL
pathway	NULL
in	NULL
Drosophila	NULL
(	NULL
19-22	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
events	NULL
linking	NULL
the	NULL
IL-1	NULL
receptor	NULL
(	NULL
IL-1R	NULL
)	NULL
signaling	NULL
complex	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
have	NULL
been	NULL
recently	NULL
characterized	NULL
.	NULL

Upon	NULL
binding	NULL
of	NULL
IL-1	NULL
to	NULL
its	NULL
receptors	NULL
(	NULL
IL-1R	NULL
)	NULL
,	NULL
IL-1R	NULL
associates	NULL
with	NULL
the	NULL
IL-1	NULL
receptor	NULL
accessory	NULL
protein	NULL
(	NULL
IL-1RAcP	NULL
)	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
then	NULL
recruits	NULL
and	NULL
activates	NULL
an	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
HDMEC	NULL
,	NULL
human	NULL
dermal	NULL
microvessel	NULL
endothelial	NULL
cells	NULL
;	NULL
IL-1	NULL
,	NULL
interleukin-1	NULL
;	NULL
IL-1R	NULL
,	NULL
IL-1	NULL
receptor	NULL
;	NULL
IL-1RacP	NULL
,	NULL
IL-1R	NULL
accessory	NULL
protein	NULL
;	NULL
IL-6	NULL
,	NULL
interleukin-6	NULL
;	NULL
IRAK	NULL
,	NULL
IL-1	NULL
receptor-associated	NULL
kinase	NULL
;	NULL
MyD88	NULL
,	NULL
myeloid	NULL
differentiation	NULL
protein	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor-kB	NULL
;	NULL
NIK	NULL
,	NULL
NF-B-inducing	NULL
kinase	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
TLR	NULL
,	NULL
toll-like	NULL
receptor	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
TRAF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
factor	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
7611	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
A	NULL
B	NULL
Fold	NULL
induction	NULL
&	NULL
Fold	NULL
induction	NULL
0	NULL
U	NULL
2	NULL
4	NULL
6	NULL
0	NULL
1	NULL
10	NULL
100	NULL
_	NULL
1008	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
LPS	NULL
(	NULL
agin	NULL
!	NULL
)	NULL

is	NULL
S	NULL
..	NULL
,	NULL
100	NULL
crocs	NULL
S	NULL
=	NULL
50	NULL
s	NULL
&	NULL
o	NULL
S	NULL
&	NULL
Relative	NULL
luciferase	NULL
activit	NULL
Relative	NULL
luciferase	NULL
activity	NULL
&	NULL
0	NULL
1	NULL
2	NULL
3	NULL
Vector	NULL
AIRAK	NULL
-	NULL
a	NULL
TRAF6	NULL
a	NULL
TRAFZ	NULL
A	NULL
MyDS	NULL
(	NULL
ug	NULL
)	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Dominant	NULL
negative	NULL
versions	NULL
of	NULL
MyD88	NULL
and	NULL
TRAF6G	NULL
but	NULL
not	NULL
TRAF2	NULL
inhibited	NULL
LPS-induced	NULL
NF-KB	NULL
activity	NULL
in	NULL
human	NULL
THP-1	NULL
cells	NULL
.	NULL

Human	NULL
THP-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
NF-	NULL
«	NULL
B-luciferase	NULL
and	NULL
B-galactosidase	NULL
reporter	NULL
vectors	NULL
and	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
MyD88	NULL
,	NULL
TRAF6	NULL
,	NULL
and	NULL
TRAF2	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
with	NULL
peDNA3	NULL
vector	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
(	NULL
A	NULL
)	NULL
or	NULL
increasing	NULL
amounts	NULL
of	NULL
LPS	NULL
for	NULL
6	NULL
h	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Some	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
different	NULL
amounts	NULL
of	NULL
MyD88	NULL
mutants	NULL
and	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
LPS	NULL
for	NULL
6	NULL
h	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
TRAF2	NULL
and	NULL
TRAF6	NULL
mutants	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
LPS	NULL
for	NULL
6	NULL
h	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Luciferase	NULL
and	NULL
B-galactosidase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Exper-imental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
time	NULL
and	NULL
dose	NULL
response	NULL
experiments	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
are	NULL
one	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
with	NULL
similar	NULL
qualitative	NULL
results	NULL
.	NULL

C	NULL
and	NULL
D	NULL
were	NULL
graphed	NULL
with	NULL
means	NULL
and	NULL
standard	NULL
deviations	NULL
of	NULL
three	NULL
or	NULL
more	NULL
experiments	NULL
.	NULL

adapter	NULL
protein	NULL
myeloid	NULL
differentiation	NULL
protein	NULL
(	NULL
MyD88	NULL
)	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

MyD88	NULL
in	NULL
turn	NULL
recruits	NULL
two	NULL
distinct	NULL
putative	NULL
serine-threo-nine	NULL
kinases	NULL
,	NULL
namely	NULL
IL-1	NULL
receptor-activated	NULL
kinase	NULL
(	NULL
IRAK	NULL
)	NULL
and	NULL
IRAK2	NULL
,	NULL
to	NULL
the	NULL
receptor	NULL
complex	NULL
(	NULL
30	NULL
)	NULL
.	NULL

IRAK	NULL
and	NULL
IRAK2	NULL
interact	NULL
subsequently	NULL
with	NULL
the	NULL
adapter	NULL
molecule	NULL
,	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
6	NULL
(	NULL
TRAF6	NULL
)	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
,	NULL
which	NULL
links	NULL
them	NULL
to	NULL
the	NULL
protein	NULL
kinase	NULL
NF-	NULL
«	NULL
B-inducing	NULL
kinase	NULL
(	NULL
NIK	NULL
)	NULL
(	NULL
83	NULL
)	NULL
.	NULL

NIK	NULL
activates	NULL
the	NULL
IkB	NULL
kinase	NULL
complex	NULL
(	NULL
IKKa	NULL
and	NULL
IKK	NULL
$	NULL
B	NULL
)	NULL
that	NULL
directly	NULL
phosphorylates	NULL
IxB	NULL
(	NULL
34-36	NULL
)	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
initiates	NULL
ubiquitin-proteasome-mediated	NULL
degradation	NULL
and	NULL
liberates	NULL
and	NULL
activates	NULL
NF-kB	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
TNF	NULL
and	NULL
its	NULL
receptor	NULL
complex	NULL
activate	NULL
TRAF2	NULL
,	NULL
but	NULL
not	NULL
TRAF6	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Downstream	NULL
signaling	NULL
pathways	NULL
of	NULL
IL-1	NULL
and	NULL
TNF	NULL
distal	NULL
to	NULL
TRAF6	NULL
and	NULL
TRAF2	NULL
converge	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
hypothesis	NULL
that	NULL
LPS	NULL
activates	NULL
NF-kB	NULL
through	NULL
IL-1	NULL
signaling	NULL
molecules	NULL
,	NULL
namely	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
IRAK2	NULL
,	NULL
and	NULL
TRAF6	NULL
in	NULL
two	NULL
LPS-responsive	NULL
cell	NULL
types	NULL
.	NULL

Dominant	NULL
negative	NULL
mutants	NULL
of	NULL
these	NULL
signaling	NULL
elements	NULL
were	NULL
transfected	NULL
into	NULL
human	NULL
monocytes	NULL
(	NULL
THP-1	NULL
cells	NULL
)	NULL
and	NULL
human	NULL
dermal	NULL
endothelial	NULL
cells	NULL
together	NULL
with	NULL
a	NULL
NF-	NULL
«	NULL
B-responsive	NULL
reporter	NULL
gene	NULL
,	NULL
and	NULL
LPS-induced	NULL
NF-kB	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
LPS	NULL
transduces	NULL
signals	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
utilizing	NULL
the	NULL
IL-1	NULL
signaling	NULL
molecules	NULL
in	NULL
both	NULL
monocytic	NULL
and	NULL
endothelial	NULL
cells	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture-Human	NULL
THP-1	NULL
cells	NULL
(	NULL
from	NULL
ATCC	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
immortalized	NULL
human	NULL
dermal	NULL
endothelial	NULL
cells	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
Dr.	NULL
Candal	NULL
of	NULL
the	NULL
Center	NULL
for	NULL
Disease	NULL
Control	NULL
,	NULL
Atlanta	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
MCDB-131	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
in	NULL
6-well	NULL
plates	NULL
.	NULL

Expression	NULL
Vectors	NULL
and	NULL
Transfection	NULL
of	NULL
THP-1	NULL
Cells-Dominant	NULL
negative	NULL
expression	NULL
vectors	NULL
of	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
IRAK2	NULL
,	NULL
TRAF2	NULL
,	NULL
TRAF6	NULL
,	NULL
and	NULL
NIK	NULL
have	NULL
been	NULL
characterized	NULL
and	NULL
described	NULL
before	NULL
(	NULL
30	NULL
,	NULL
32	NULL
,	NULL
$	NULL
3	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
used	NULL
for	NULL
transfection	NULL
with	NULL
FuGene	NULL
6	NULL
Transfection	NULL
Reagent	NULL
(	NULL
Boeh-ringer	NULL
Mannheim	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
in	NULL
RPMI	NULL
LPS	NULL
Activates	NULL
NF-kB	NULL
through	NULL
IL-1	NULL
Signaling	NULL
Molecules	NULL
aoc	NULL
o	NULL
N	NULL
0	NULL
o	NULL
Relative	NULL
luciferase	NULL
activity	NULL
-	NULL
Jp	NULL
>	NULL
Io	NULL
P	NULL
lel	NULL
co	NULL
o	NULL
o	NULL
©	NULL
[	NULL
=	NULL
]	NULL
=	NULL
]	NULL
Vector	NULL
-	NULL
A	NULL
NK	NULL
-	NULL
a	NULL
MyDé8	NULL
A	NULL
IRAK	NULL
A	NULL
IRAK2	NULL
A	NULL
TRAFS	NULL
IL-1R	NULL
-	NULL
A	NULL
TRAF	NULL
2	NULL
antagonist	NULL
Relative	NULL
luciferase	NULL
activity	NULL
Vector	NULL
IL-1R	NULL
ANK	NULL
--	NULL
4	NULL
MyD38	NULL
0	NULL
wIRAK	NULL
--	NULL
)	NULL
TRare	NULL
antagonist	NULL
Relative	NULL
luciferase	NULL
activity	NULL
Vector	NULL
A	NULL
NK	NULL
ATRAF	NULL
2	NULL
A	NULL
MyD88	NULL
A	NULL
RAK	NULL
A	NULL
TRAF	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Dominant	NULL
negative	NULL
versions	NULL
of	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
IRAK2	NULL
,	NULL
TRAF6	NULL
,	NULL
and	NULL
NIK	NULL
but	NULL
not	NULL
TRAF2	NULL
inhibited	NULL
LPS-induced	NULL
NF-kB	NULL
activity	NULL
in	NULL
HDMEC	NULL
.	NULL

Human	NULL
dermal	NULL
endothelial	NULL
cells	NULL
grown	NULL
on	NULL
6-well	NULL
plates	NULL
were	NULL
transfected	NULL
with	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
IRAK2	NULL
,	NULL
TRAF6	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
NIK	NULL
as	NULL
well	NULL
as	NULL
reporter	NULL
genes	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
amount	NULL
of	NULL
total	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
with	NULL
peDNA3	NULL
vector	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
ng/ml	NULL
LPS	NULL
(	NULL
A	NULL
)	NULL
,	NULL
400	NULL
units/ml	NULL
human	NULL
IL-1	NULL
(	NULL
B	NULL
)	NULL
,	NULL
200	NULL
units/ml	NULL
human	NULL
TNF-a	NULL
(	NULL
C	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
Some	NULL
cells	NULL
were	NULL
also	NULL
treated	NULL
with	NULL
100	NULL
ng/ml	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
for	NULL
6	NULL
h	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
luciferase	NULL
activity	NULL
was	NULL
obtained	NULL
with	NULL
luciferase	NULL
assay	NULL
and	NULL
normalized	NULL
with	NULL
-galactosidase	NULL
activity	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
one	NULL
representative	NULL
experiment	NULL
of	NULL
two	NULL
experiments	NULL
with	NULL
similar	NULL
qualitative	NULL
results	NULL
.	NULL

with	NULL
10	NULL
%	NULL
serum	NULL
.	NULL

Reporter	NULL
genes	NULL
pCMV-B-galactosidase	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
and	NULL
ELAM-NF-	NULL
«	NULL
B-luciferase	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
and	NULL
peDNA3	NULL
empty	NULL
vector	NULL
or	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
TRAF6	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
NIK	NULL
(	NULL
3	NULL
ug	NULL
each	NULL
)	NULL
were	NULL
used	NULL
.	NULL

After	NULL
a	NULL
24-h	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
100	NULL
ng/ml	NULL
LPS	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
lysed	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
Promega	NULL
kit	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
a	NULL
luminom-eter	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
calorimetric	NULL
method	NULL
to	NULL
normalize	NULL
transfection	NULL
efficiency	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
means	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Transfection	NULL
of	NULL
Human	NULL
Dermal	NULL
Endothelial	NULL
Cells-Transfection	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
same	NULL
method	NULL
described	NULL
above	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
luciferase	NULL
construct	NULL
DNA	NULL
was	NULL
1.5	NULL
ug	NULL
,	NULL
and	NULL
empty	NULL
vector	NULL
and	NULL
various	NULL
dominant	NULL
negative	NULL
constructs	NULL
were	NULL
2	NULL
ug	NULL
each	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
for	NULL
24	NULL
h	NULL
and	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
100	NULL
ng/ml	NULL
LPS	NULL
,	NULL
human	NULL
TNF-a	NULL
(	NULL
200	NULL
units/ml	NULL
,	NULL
Genzyme	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
recombinant	NULL
human	NULL
IL-1	NULL
(	NULL
400	NULL
units/ml	NULL
,	NULL
Genzyme	NULL
)	NULL
,	NULL
and	NULL
recombinant	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
(	NULL
100	NULL
ng/ml	NULL
,	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
serum-containing	NULL
MCDB-131	NULL
medium	NULL
.	NULL

Reverse	NULL
Transcription-Polymerase	NULL
Chain	NULL
Reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
Analy-sis-Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
HDMEC	NULL
and	NULL
THP-1	NULL
cells	NULL
using	NULL
a	NULL
Qiagen	NULL
kit	NULL
(	NULL
Valencia	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
treated	NULL
with	NULL
RNase-free	NULL
DNase	NULL
I	NULL
.	NULL

For	NULL
RT	NULL
reaction	NULL
,	NULL
the	NULL
SuperScript	NULL
``	NULL
Preamplification	NULL
system	NULL
(	NULL
Life	NULL
Technolo-gies	NULL
,	NULL
Inc.	NULL
)	NULL
was	NULL
applied	NULL
.	NULL

PCR	NULL
amplification	NULL
was	NULL
performed	NULL
with	NULL
Tag	NULL
polymerase	NULL
(	NULL
Qiagen	NULL
,	NULL
Valencia	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
28	NULL
cycles	NULL
at	NULL
95	NULL
°C	NULL
for	NULL
40	NULL
s	NULL
,	NULL
54	NULL
°C	NULL
for	NULL
40	NULL
s	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
.	NULL

PCR	NULL
primers	NULL
for	NULL
TLR2	NULL
were	NULL
55-GC-CAAAGTCTTGATTGATTGG	NULL
and	NULL
5'-TTGAAGTTCTCCAGCTCCTG	NULL
.	NULL

PCR	NULL
primers	NULL
for	NULL
TLR4	NULL
were	NULL
5-TGGATACGTTTCCTTATAAG	NULL
and	NULL
5'-GAAATGGAGGCACCCCTTC	NULL
.	NULL

GAPDH	NULL
primers	NULL
were	NULL
obtained	NULL
from	NULL
CLONTECH	NULL
.	NULL

Immunostaining	NULL
and	NULL
Immunoblotting-Smeared	NULL
THP-1	NULL
cell	NULL
and	NULL
cultured	NULL
HDMEC	NULL
on	NULL
slides	NULL
were	NULL
fixed	NULL
with	NULL
acetone	NULL
for	NULL
5	NULL
min	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
rabbit	NULL
anti-TLR2	NULL
and	NULL
TLR-4	NULL
antibody	NULL
(	NULL
1:100	NULL
)	NULL
and	NULL
rabbit	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
LPS	NULL
Activates	NULL
NF-kB	NULL
through	NULL
IL-1	NULL
Signaling	NULL
Molecules	NULL
7613	NULL
RT	NULL
3	NULL
o	NULL
es	NULL
4	NULL
-	NULL
dermal	NULL
EC	NULL
-	NULL
dermal	NULL
EC	NULL
-	NULL
THP-1	NULL
-	NULL
THP	NULL
fo	NULL
¥	NULL
I	NULL
.	NULL

&	NULL
~	NULL
>	NULL
R	NULL
-	NULL
sos	NULL
»	NULL
GAPDH	NULL
im	NULL
--	NULL
-1018	NULL
bp	NULL
1	NULL
2	NULL
B8	NULL
4	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Expression	NULL
of	NULL
TLR2	NULL
and	NULL
TLR4	NULL
in	NULL
HDMEC	NULL
and	NULL
THP-1	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
TLR2	NULL
mRNA	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
347	NULL
base	NULL
pairs	NULL
)	NULL
and	NULL
TLR4	NULL
mRNA	NULL
(	NULL
middle	NULL
panel	NULL
,	NULL
548	NULL
base	NULL
pairs	NULL
)	NULL
in	NULL
HDMEC	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
and	NULL
THP-1	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
was	NULL
analyzed	NULL
by	NULL
PCR	NULL
following	NULL
reverse	NULL
transcription	NULL
(	NULL
RT	NULL
;	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
without	NULL
RT	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
GAPDH	NULL
expression	NULL
was	NULL
used	NULL
as	NULL
control	NULL
(	NULL
lower	NULL
panel	NULL
,	NULL
983	NULL
base	NULL
pairs	NULL
)	NULL
.	NULL

Labels	NULL
of	NULL
base	NULL
pairs	NULL
at	NULL
the	NULL
right	NULL
are	NULL
DNA	NULL
standard	NULL
markers	NULL
.	NULL

IgG	NULL
following	NULL
the	NULL
instructions	NULL
on	NULL
a	NULL
DACO	NULL
immunostaining	NULL
kit	NULL
.	NULL

The	NULL
anti-TLR2	NULL
and	NULL
anti-TLR4	NULL
antisera	NULL
were	NULL
raised	NULL
against	NULL
synthetic	NULL
pep-tides	NULL
(	NULL
extracellular	NULL
domains	NULL
of	NULL
TLR2	NULL
and	NULL
TLR4	NULL
)	NULL
by	NULL
BABCO	NULL
(	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
synthetic	NULL
peptide	NULL
for	NULL
TLR2	NULL
was	NULL
a	NULL
27-amino	NULL
acid	NULL
peptide	NULL
,	NULL
starting	NULL
at	NULL
amino	NULL
acid	NULL
residue	NULL
277	NULL
of	NULL
the	NULL
mature	NULL
hTLR2	NULL
(	NULL
FRASDNDRVIDPGKVETLTIRRLHIPR	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
peptide	NULL
for	NULL
TLRA4	NULL
was	NULL
a	NULL
23-amino	NULL
acid	NULL
peptide	NULL
,	NULL
starting	NULL
at	NULL
amino	NULL
acid	NULL
201	NULL
of	NULL
mature	NULL
hTLR4	NULL
(	NULL
FKEIRHKLTLRNNFDLSLNVMKT	NULL
)	NULL
.	NULL

Following	NULL
immunoper-oxidase	NULL
staining	NULL
,	NULL
the	NULL
representative	NULL
fields	NULL
were	NULL
photographed	NULL
.	NULL

THP-1	NULL
and	NULL
HDMEC	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
Laemmli	NULL
buffer	NULL
and	NULL
separated	NULL
with	NULL
a	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
then	NULL
transferred	NULL
onto	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
,	NULL
and	NULL
then	NULL
the	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
anti-TLR2	NULL
,	NULL
anti-TLR4	NULL
antibodies	NULL
,	NULL
and	NULL
prebleeds	NULL
corresponding	NULL
to	NULL
each	NULL
antibody	NULL
(	NULL
1:2,000	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
antibody	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
developed	NULL
with	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
ECL	NULL
detection	NULL
kit	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
A	NULL
series	NULL
of	NULL
defense	NULL
mechanisms	NULL
are	NULL
triggered	NULL
in	NULL
vertebrates	NULL
and	NULL
invertebrates	NULL
in	NULL
response	NULL
to	NULL
Gram-negative	NULL
bacterial	NULL
infections	NULL
by	NULL
sensing	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

LPS-induced	NULL
signal	NULL
relay	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
initiated	NULL
following	NULL
its	NULL
binding	NULL
to	NULL
specific	NULL
cellular	NULL
receptors	NULL
which	NULL
then	NULL
triggers	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
4-12	NULL
)	NULL
in	NULL
various	NULL
LPS-responsive	NULL
cell	NULL
types	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
functional	NULL
,	NULL
signal-transducing	NULL
component	NULL
of	NULL
the	NULL
putative	NULL
LPS	NULL
receptor	NULL
complex	NULL
and	NULL
the	NULL
signaling	NULL
pathways	NULL
involved	NULL
in	NULL
LPS-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
have	NULL
remained	NULL
elusive	NULL
.	NULL

Recent	NULL
findings	NULL
suggested	NULL
that	NULL
LPS	NULL
might	NULL
use	NULL
signaling	NULL
molecules	NULL
of	NULL
the	NULL
TLR	NULL
and	NULL
IL-1R	NULL
superfamilies	NULL
to	NULL
transduce	NULL
signals	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
potential	NULL
involvement	NULL
of	NULL
IL-1	NULL
and	NULL
TNF	NULL
signal	NULL
transducers	NULL
in	NULL
LPS	NULL
signaling	NULL
in	NULL
two	NULL
LPS-responsive	NULL
cell	NULL
types	NULL
,	NULL
HDMEC	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
we	NULL
cotransfected	NULL
dominant	NULL
negative	NULL
constructs	NULL
of	NULL
various	NULL
components	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
cascades	NULL
for	NULL
IL-1	NULL
and	NULL
TNF	NULL
together	NULL
with	NULL
NF-	NULL
«	NULL
B-luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

LPS	NULL
induced	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
a	NULL
time-	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
and	NULL
dose-dependent	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
manner	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Activation	NULL
of	NULL
NF-kB	NULL
reached	NULL
a	NULL
maximum	NULL
at	NULL
a	NULL
LPS	NULL
concentration	NULL
of	NULL
100	NULL
ng/ml	NULL
and	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
for	NULL
6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
also	NULL
obtained	NULL
from	NULL
endothelial	NULL
cells	NULL
.	NULL

A	NULL
mutant	NULL
version	NULL
of	NULL
MyD88	NULL
(	NULL
AMyD88	NULL
)	NULL
,	NULL
encoding	NULL
only	NULL
for	NULL
the	NULL
COOH-terminal	NULL
toll-IL-1R-like	NULL
domain	NULL
,	NULL
which	NULL
abrogates	NULL
IL-1R-induced	NULL
NF-kB	NULL
activation	NULL
(	NULL
30	NULL
)	NULL
,	NULL
inhibited	NULL
both	NULL
LPS-	NULL
and	NULL
IL-1-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Figs	NULL
.	NULL

1C	NULL
and	NULL
2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
but	NULL
not	NULL
TNF-induced	NULL
NF-kB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

IRAK	NULL
and	NULL
IRAK-2	NULL
are	NULL
two	NULL
additional	NULL
proximal	NULL
mediators	NULL
of	NULL
the	NULL
IL-1R	NULL
A	NULL
THP-I	NULL
HDMEC	NULL
®	NULL
C3	NULL
¥	NULL
&	NULL
``	NULL
``	NULL
R	NULL
j	NULL
¢	NULL
Ctrl	NULL
8	NULL
j	NULL
a	NULL
7	NULL
6	NULL
j	NULL
r	NULL
x	NULL
mo	NULL
%	NULL
3	NULL
``	NULL
B	NULL
ﬁ-ﬁg	NULL
*	NULL
%	NULL
&	NULL
@	NULL
l	NULL
ar	NULL
TLR2	NULL
A	NULL
TLR4	NULL
_	NULL
``	NULL
``	NULL
~oq	NULL
\	NULL
%	NULL
Antiserum	NULL
Prebleeds	NULL
-	NULL
HDMEC	NULL
EHP-T	NULL
HDVEC	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Immunostaining	NULL
and	NULL
immunoblotting	NULL
.	NULL

In	NULL
pare	NULL
!	NULL

A	NULL
,	NULL
THP-1	NULL
cells	NULL
(	NULL
a	NULL
,	NULL
c	NULL
,	NULL
and	NULL
e	NULL
)	NULL
and	NULL
HDMEC	NULL
cells	NULL
(	NULL
b	NULL
,	NULL
d	NULL
,	NULL
and	NULL
f	NULL
)	NULL
were	NULL
immunostained	NULL
with	NULL
rabbit	NULL
IgG	NULL
(	NULL
a	NULL
and	NULL
6	NULL
)	NULL
,	NULL
anti-TLR2	NULL
(	NULL
c	NULL
and	NULL
d	NULL
)	NULL
,	NULL
and	NULL
anti-TLR4	NULL
(	NULL
e	NULL
and	NULL
f	NULL
)	NULL
(	NULL
1:100	NULL
)	NULL
.	NULL

In	NULL
panel	NULL
B	NULL
,	NULL
THP-1	NULL
and	NULL
HDMEC	NULL
cell	NULL
lysates	NULL
were	NULL
resolved	NULL
with	NULL
SDS-PAGE	NULL
and	NULL
probed	NULL
with	NULL
anti-TLR2	NULL
,	NULL
anti-TLR4	NULL
antibodies	NULL
,	NULL
and	NULL
corresponding	NULL
prebleeds	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
right	NULL
.	NULL

The	NULL
apparent	NULL
molecular	NULL
masses	NULL
for	NULL
TLR2	NULL
and	NULL
TLR4	NULL
were	NULL
85	NULL
kDa	NULL
and	NULL
92	NULL
kDa	NULL
,	NULL
respectively	NULL
.	NULL

<	NULL
-	NULL
9	NULL
%	NULL
4	NULL
kDa	NULL
4-974	NULL
kDa	NULL
signaling	NULL
complex	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Dominant	NULL
negative	NULL
constructs	NULL
of	NULL
IRAK	NULL
(	NULL
AIRAK	NULL
)	NULL
and	NULL
IRAK2	NULL
(	NULL
AIRAK2	NULL
)	NULL
inhibited	NULL
both	NULL
LPS-	NULL
(	NULL
Figs	NULL
.	NULL

1D	NULL
and	NULL
24	NULL
)	NULL
and	NULL
IL-1R-mediated	NULL
NF-kB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
but	NULL
not	NULL
TNF-induced	NULL
NF-kB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

NF-kB	NULL
activation	NULL
induced	NULL
by	NULL
various	NULL
cytokine	NULL
receptors	NULL
is	NULL
mediated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
TRAF	NULL
adapter	NULL
family	NULL
.	NULL

While	NULL
TRAF2	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
NF-KB	NULL
activation	NULL
by	NULL
TNFR-1	NULL
and	NULL
TNFR-2	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
TRAF6	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
IL-1	NULL
signaling	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
next	NULL
determined	NULL
whether	NULL
dominant	NULL
negative	NULL
versions	NULL
of	NULL
TRAF6	NULL
(	NULL
ATRAF6	NULL
)	NULL
or	NULL
TRAF2	NULL
(	NULL
ATRAF2	NULL
)	NULL
could	NULL
act	NULL
to	NULL
inhibit	NULL
LPS-induced	NULL
NF-KB	NULL
activity	NULL
.	NULL

ATRAF-6	NULL
but	NULL
not	NULL
ATRAF2	NULL
significantly	NULL
impaired	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
suggesting	NULL
that	NULL
TRAF6	NULL
may	NULL
act	NULL
as	NULL
an	NULL
additional	NULL
downstream	NULL
mediator	NULL
of	NULL
LPS-induced	NULL
NF-kB	NULL
activation	NULL
cascade	NULL
(	NULL
Figs	NULL
.	NULL

1D	NULL
and	NULL
24	NULL
)	NULL
.	NULL

ATRAF2	NULL
blocked	NULL
TNF-induced	NULL
NF-KB	NULL
activation	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
but	NULL
not	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Figs	NULL
.	NULL

1D	NULL
and	NULL
24	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
pathways	NULL
for	NULL
IL-1	NULL
and	NULL
TNF-a	NULL
signaling	NULL
converge	NULL
at	NULL
the	NULL
level	NULL
of	NULL
NIK	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
whether	NULL
dominant	NULL
negative	NULL
NIK	NULL
mutant	NULL
(	NULL
ANIK	NULL
)	NULL
would	NULL
block	NULL
LPS-induced	NULL
,	NULL
as	NULL
well	NULL
as	NULL
IL-1-	NULL
and	NULL
TNF-induced	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
ANIK	NULL
blocked	NULL
NF-kB	NULL
activation	NULL
induced	NULL
by	NULL
LPS	NULL
,	NULL
IL-1	NULL
,	NULL
and	NULL
TNF-	NULL
@	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

IL-1	NULL
receptor	NULL
antagonist	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
but	NULL
inhibited	NULL
IL-l-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
suggests	NULL
that	NULL
NF-KB	NULL
activation	NULL
that	NULL
we	NULL
measured	NULL
following	NULL
6	NULL
h	NULL
of	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
7614	NULL
TNF	NULL
IL-1	NULL
LPS	NULL
HTNFR	NULL
HIL-1R	NULL
HTLR	NULL
or	NULL
LPS	NULL
receptor	NULL
?	NULL

TRADD	NULL
MyDss	NULL
RIP	NULL
IRAK	NULL
TRAF2	NULL
/IRAK2	NULL
TRAFE	NULL
NIK	NULL
IKKo	NULL
:	NULL
.	NULL

IB	NULL
I	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Schematic	NULL
diagram	NULL
of	NULL
signaling	NULL
cascades	NULL
for	NULL
LPS	NULL
,	NULL
IL-1	NULL
,	NULL
and	NULL
TNF	NULL
.	NULL

The	NULL
diagram	NULL
illustrates	NULL
that	NULL
LPS	NULL
utilizes	NULL
IL-1	NULL
signaling	NULL
molecules	NULL
(	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
IRAK2	NULL
,	NULL
and	NULL
TRAF6	NULL
)	NULL
but	NULL
not	NULL
TNF	NULL
signaling	NULL
molecules	NULL
(	NULL
TRAF2	NULL
)	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
cells	NULL
is	NULL
not	NULL
due	NULL
to	NULL
an	NULL
autocrine	NULL
effect	NULL
such	NULL
as	NULL
LPS-induced	NULL
IL-1	NULL
release	NULL
from	NULL
endothelial	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
LPS	NULL
stimulation	NULL
of	NULL
endothelial	NULL
cells	NULL
and	NULL
THP-1	NULL
cells	NULL
triggers	NULL
an	NULL
IL-1R-like	NULL
signal	NULL
relay	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Further	NULL
support	NULL
for	NULL
this	NULL
concept	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
observation	NULL
of	NULL
a	NULL
15-year-old	NULL
girl	NULL
with	NULL
recurrent	NULL
infections	NULL
who	NULL
was	NULL
found	NULL
to	NULL
be	NULL
resistant	NULL
to	NULL
both	NULL
LPS	NULL
and	NULL
IL-1	NULL
stimulation	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
authors	NULL
suggested	NULL
that	NULL
resistance	NULL
to	NULL
LPS	NULL
and	NULL
IL-1	NULL
was	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
very	NULL
early	NULL
in	NULL
the	NULL
common	NULL
signaling	NULL
pathway	NULL
for	NULL
LPS	NULL
and	NULL
IL-1	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
experiments	NULL
with	NULL
IL-1R	NULL
antagonist	NULL
also	NULL
suggest	NULL
that	NULL
LPS	NULL
does	NULL
not	NULL
use	NULL
IL-1	NULL
receptor	NULL
to	NULL
transduce	NULL
signals	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Although	NULL
recent	NULL
findings	NULL
imply	NULL
that	NULL
TLR2	NULL
or	NULL
other	NULL
members	NULL
of	NULL
the	NULL
TLR	NULL
family	NULL
,	NULL
which	NULL
use	NULL
the	NULL
IL-1R	NULL
signaling	NULL
pathway	NULL
,	NULL
might	NULL
be	NULL
an	NULL
important	NULL
mediator	NULL
for	NULL
LPS	NULL
signaling	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
,	NULL
further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
identify	NULL
naturally	NULL
existing	NULL
LPS	NULL
receptors	NULL
in	NULL
LPS-responsive	NULL
cells	NULL
.	NULL

Beutler	NULL
and	NULL
coworkers	NULL
(	NULL
25	NULL
)	NULL
recently	NULL
reported	NULL
that	NULL
TLR4	NULL
is	NULL
the	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
LPS	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
mutated	NULL
in	NULL
the	NULL
LPS-non-responsive	NULL
C3H-HeJ	NULL
mice	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
TLR2	NULL
and	NULL
TLR4	NULL
message	NULL
in	NULL
HDMEC	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
RT-PCR	NULL
.	NULL

Human	NULL
THP-1	NULL
and	NULL
HDMEC	NULL
were	NULL
found	NULL
to	NULL
express	NULL
significant	NULL
levels	NULL
of	NULL
both	NULL
TLR2	NULL
and	NULL
TLR4	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Expression	NULL
levels	NULL
of	NULL
TLR2	NULL
appeared	NULL
to	NULL
be	NULL
stronger	NULL
in	NULL
THP-1	NULL
whereas	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
TLR4	NULL
appeared	NULL
to	NULL
be	NULL
stronger	NULL
in	NULL
HDMEC	NULL
.	NULL

Expression	NULL
of	NULL
TLR2	NULL
and	NULL
TLR4	NULL
was	NULL
confirmed	NULL
with	NULL
Northern	NULL
analysis	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Immunohistochemistry	NULL
and	NULL
immunoblotting	NULL
data	NULL
demonstrate	NULL
that	NULL
TLR2	NULL
and	NULL
TLR4	NULL
proteins	NULL
are	NULL
expressed	NULL
on	NULL
THP-1	NULL
cells	NULL
and	NULL
HDMEC	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Staining	NULL
was	NULL
absent	NULL
in	NULL
THP-1	NULL
and	NULL
HDMEC	NULL
incubated	NULL
without	NULL
the	NULL
first	NULL
antibody	NULL
or	NULL
incubated	NULL
with	NULL
rabbit	NULL
IgG	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
TLR2	NULL
and	NULL
TLR4	NULL
are	NULL
expressed	NULL
in	NULL
endothelial	NULL
and	NULL
monocytic	NULL
cells	NULL
and	NULL
may	NULL
represent	NULL
a	NULL
signaling	NULL
component	NULL
of	NULL
a	NULL
cellular	NULL
receptor	NULL
for	NULL
LPS	NULL
which	NULL
signals	NULL
through	NULL
an	NULL
IL-l-like	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
in	NULL
endothelial	NULL
and	NULL
THP-1	NULL
cells	NULL
that	NULL
LPS-induced	NULL
NF-KB	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
IL-1R	NULL
signaling	NULL
molecules	NULL
,	NULL
namely	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
IRAK2	NULL
,	NULL
and	NULL
TRAF6	NULL
,	NULL
but	NULL
not	NULL
the	NULL
TNF	NULL
signaling	NULL
molecule	NULL
,	NULL
TRAF2	NULL
.	NULL

We	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
TLR2	NULL
and	NULL
TLR4	NULL
are	NULL
expressed	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
two	NULL
LPS-responsive	NULL
cell	NULL
types	NULL
,	NULL
endothelial	NULL
cells	NULL
and	NULL
THP-1	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
a	NULL
crucial	NULL
signaling	NULL
component	NULL
in	NULL
the	NULL
LPS	NULL
receptor	NULL
complex	NULL
may	NULL
belong	NULL
to	NULL
the	NULL
LPS	NULL
Activates	NULL
NF-kB	NULL
through	NULL
IL-1	NULL
Signaling	NULL
Molecules	NULL
IL-1	NULL
receptor/TLR	NULL
superfamily	NULL
,	NULL
and	NULL
the	NULL
LPS	NULL
signaling	NULL
cascade	NULL
uses	NULL
an	NULL
analogous	NULL
molecular	NULL
framework	NULL
for	NULL
signaling	NULL
as	NULL
IL-1	NULL
.	NULL

MyD88	NULL
appears	NULL
to	NULL
represent	NULL
the	NULL
most	NULL
upstream	NULL
mediator	NULL
of	NULL
the	NULL
LPS-mediated	NULL
signaling	NULL
cascade	NULL
,	NULL
which	NULL
ultimately	NULL
activates	NULL
NF-kB	NULL
,	NULL
thus	NULL
driving	NULL
transcriptional	NULL
activation	NULL
of	NULL
several	NULL
cytokines	NULL
.	NULL

Thus	NULL
,	NULL
MyD88	NULL
may	NULL
represent	NULL
a	NULL
potentially	NULL
useful	NULL
therapeutic	NULL
target	NULL
to	NULL
control	NULL
the	NULL
molecular	NULL
switch	NULL
from	NULL
innate	NULL
to	NULL
the	NULL
adaptive	NULL
immune	NULL
response	NULL
.	NULL

REFERENCES	NULL
.	NULL

Wenzel	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Pinsky	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Clin	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

22	NULL
,	NULL
407-413	NULL
2	NULL
.	NULL

Rietschel	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Brade	NULL
,	NULL
H.	NULL
,	NULL
Holst	NULL
,	NULL
O.	NULL
,	NULL
Brade	NULL
,	NULL
L.	NULL
,	NULL
Muller-Loennies	NULL
,	NULL
S.	NULL
,	NULL
Mamat	NULL
,	NULL
U.	NULL
,	NULL
Z	NULL
&	NULL
hringer	NULL
,	NULL
U.	NULL
,	NULL
Beckmann	NULL
,	NULL
F.	NULL
,	NULL
Seydel	NULL
,	NULL
U.	NULL
,	NULL
Brandenburg	NULL
,	NULL
K.	NULL
,	NULL
Ulmer	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Mattern	NULL
,	NULL
T.	NULL
,	NULL
Heine	NULL
,	NULL
H.	NULL
,	NULL
Schletter	NULL
,	NULL
J.	NULL
,	NULL
Loppnow	NULL
,	NULL
H.	NULL
,	NULL
Schinbeck	NULL
,	NULL
U.	NULL
,	NULL
Flad	NULL
,	NULL
H.-D.	NULL
,	NULL
Hauschidt	NULL
,	NULL
S.	NULL
,	NULL
Schade	NULL
,	NULL
U.	NULL
F.	NULL
,	NULL
Di	NULL
Padova	NULL
,	NULL
F.	NULL
,	NULL
Kusumoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Schumann	NULL
,	NULL
R.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

216	NULL
,	NULL
40-81	NULL
.	NULL

Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
,	NULL
125-130	NULL
.	NULL

Arditi	NULL
,	NULL
M.	NULL
,	NULL
Zhou	NULL
,	NULL
J.	NULL
,	NULL
Dorio	NULL
,	NULL
R.	NULL
,	NULL
Rong	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Kim	NULL
,	NULL
K.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

61	NULL
,	NULL
3149-3156	NULL
5	NULL
.	NULL

Frey	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Miller	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Gullstein	NULL
Jahr	NULL
,	NULL
T.	NULL
,	NULL
Sundan	NULL
,	NULL
A.	NULL
,	NULL
Bazil	NULL
,	NULL
V.	NULL
,	NULL
Espevik	NULL
,	NULL
T.	NULL
,	NULL
Finlay	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
1665-1670	NULL
6	NULL
.	NULL

Pugin	NULL
,	NULL
J.	NULL
,	NULL
Schurer-Maly	NULL
,	NULL
C.-C.	NULL
,	NULL
Letureq	NULL
,	NULL
D.	NULL
,	NULL
Moriarty	NULL
,	NULL
A.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2744-2751	NULL
7	NULL
.	NULL

Arditi	NULL
,	NULL
M.	NULL
,	NULL
Zhou	NULL
,	NULL
J.	NULL
,	NULL
Torres	NULL
,	NULL
M.	NULL
,	NULL
Durden	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Stins	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kim	NULL
,	NULL
K.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
3994-4003	NULL
8	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Gold	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
4148-4152	NULL
9	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Lemke	NULL
,	NULL
K.	NULL
,	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Pelech	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
14955-14962	NULL
10	NULL
.	NULL

Reimann	NULL
,	NULL
T.	NULL
,	NULL
Biischer	NULL
,	NULL
D.	NULL
,	NULL
Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Krautwald	NULL
,	NULL
S.	NULL
,	NULL
Lohmann-Matthes	NULL
,	NULL
M.-L.	NULL
,	NULL
and	NULL
Baccarini	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
5740-5749	NULL
11	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
Bibbs	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
808-811	NULL
12	NULL
.	NULL

Schumann	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Pfeil	NULL
,	NULL
D.	NULL
,	NULL
Lamping	NULL
,	NULL
N.	NULL
,	NULL
Kirschning	NULL
,	NULL
C.	NULL
,	NULL
Scherzinger	NULL
,	NULL
G.	NULL
,	NULL
Schlag	NULL
,	NULL
P.	NULL
,	NULL
Karawajew	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Herrmann	NULL
,	NULL
F.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
2805-2814	NULL
13	NULL
.	NULL

Haeffner	NULL
,	NULL
A.	NULL
,	NULL
Thieblemont	NULL
,	NULL
N.	NULL
,	NULL
Deas	NULL
,	NULL
O.	NULL
,	NULL
Marelli	NULL
,	NULL
O.	NULL
,	NULL
Charpentier	NULL
,	NULL
B.	NULL
,	NULL
Senik	NULL
,	NULL
A.	NULL
,	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Haeffner-Cavaillon	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Hirsch	NULL
,	NULL
F.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
1310-1314	NULL
14	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Donald	NULL
,	NULL
R.	NULL
,	NULL
Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Hawiger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
11803-11810	NULL
15	NULL
.	NULL

Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Veach	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Carlisle	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
Hawiger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
9887-9891	NULL
16	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
13-20	NULL
17	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
R19-R22	NULL
18	NULL
.	NULL

Belvin	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
and	NULL
Anderson	NULL
,	NULL
K.	NULL
V.	NULL
(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
.	NULL

Dev	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
393-416	NULL
19	NULL
.	NULL

Chaudhary	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Ferguson	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Nguyen	NULL
,	NULL
V.	NULL
(	NULL
1998	NULL
)	NULL
Blood	NULL
91	NULL
,	NULL
4020-4027	NULL
20	NULL
.	NULL

Heguy	NULL
,	NULL
A.	NULL
,	NULL
Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Macchia	NULL
,	NULL
G.	NULL
,	NULL
Telford	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Melli	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
2605-2609	NULL
21	NULL
.	NULL

Rock	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
Hardiman	NULL
,	NULL
G.	NULL
,	NULL
Timans	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Kastelein	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Bazan	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

95	NULL
,	NULL
588-593	NULL
22	NULL
.	NULL

Medzhitov	NULL
,	NULL
R.	NULL
,	NULL
Preston-Hurlburt	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Janeway	NULL
,	NULL
C.	NULL
A.	NULL
Jr.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
888	NULL
,	NULL
394-397	NULL
23	NULL
.	NULL

Yang	NULL
,	NULL
R.-B	NULL
.	NULL

,	NULL
Mark	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Gray	NULL
,	NULL
A.	NULL
,	NULL
Huang	NULL
,	NULL
A.	NULL
,	NULL
Xie	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Zhang	NULL
,	NULL
M.	NULL
,	NULL
Goddard	NULL
,	NULL
A.	NULL
,	NULL
Wood	NULL
,	NULL
W.	NULL
I.	NULL
,	NULL
Gurney	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Godowski	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Nature	NULL
895	NULL
,	NULL
284-288	NULL
24	NULL
.	NULL

Kirschning	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Wesche	NULL
,	NULL
H.	NULL
,	NULL
Ayres	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188	NULL
,	NULL
2091-2097	NULL
25	NULL
.	NULL

Poltorak	NULL
,	NULL
A.	NULL
,	NULL
He	NULL
,	NULL
X.	NULL
,	NULL
Smirnova	NULL
,	NULL
I.	NULL
,	NULL
Liu	NULL
,	NULL
M.-Y	NULL
.	NULL

,	NULL
Van	NULL
Huffel	NULL
,	NULL
C.	NULL
,	NULL
Du	NULL
,	NULL
X.	NULL
,	NULL
Birdwell	NULL
,	NULL
D.	NULL
,	NULL
Alejos	NULL
,	NULL
E.	NULL
,	NULL
Silva	NULL
,	NULL
M.	NULL
,	NULL
Galanos	NULL
,	NULL
C.	NULL
,	NULL
Freudenberg	NULL
,	NULL
M.	NULL
,	NULL
Ricciardi-Castagnoli	NULL
,	NULL
P.	NULL
,	NULL
Layton	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Science	NULL
282	NULL
,	NULL
2085-2088	NULL
26	NULL
.	NULL

Huang	NULL
,	NULL
J.	NULL
,	NULL
Gao	NULL
,	NULL
X.	NULL
,	NULL
Li	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Cao	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
12829-12832	NULL
27	NULL
.	NULL

Croston	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Cao	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
16514-16517	NULL
28	NULL
.	NULL

Wesche	NULL
,	NULL
H.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Shillinglaw	NULL
,	NULL
W.	NULL
,	NULL
Li	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Cao	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Immunity	NULL
7	NULL
,	NULL
837-847	NULL
29	NULL
.	NULL

Burns	NULL
,	NULL
K.	NULL
,	NULL
Martinon	NULL
,	NULL
F.	NULL
,	NULL
Esslinger	NULL
,	NULL
C.	NULL
,	NULL
Pahl	NULL
,	NULL
H.	NULL
,	NULL
Schneider	NULL
,	NULL
P.	NULL
,	NULL
Bodmer	NULL
,	NULL
J.-L.	NULL
,	NULL
Di	NULL
Marco	NULL
,	NULL
F.	NULL
,	NULL
French	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Tschopp	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
12203-12209	NULL
30	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
Ni	NULL
,	NULL
J.	NULL
,	NULL
Feng	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
1612-1615	NULL
31	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
Xiong	NULL
,	NULL
J.	NULL
,	NULL
Takeuchi	NULL
,	NULL
M.	NULL
,	NULL
Kurama	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
383	NULL
,	NULL
443-446	NULL
32	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
Natoli	NULL
,	NULL
G.	NULL
,	NULL
Saccani	NULL
,	NULL
S.	NULL
,	NULL
Levrero	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mantovani	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187	NULL
,	NULL
2097-2101	NULL
33	NULL
.	NULL

Song	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Regnier	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Kirschning	NULL
,	NULL
C.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
Cao	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Rothe	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
9792-9796	NULL
34	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Hayakawa	NULL
,	NULL
M.	NULL
,	NULL
Rothwarf	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Zandi	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
888	NULL
,	NULL
548-554	NULL
35	NULL
.	NULL

Stancovski	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
91	NULL
,	NULL
299-302	NULL
36	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
895	NULL
,	NULL
225-226	NULL
37	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
Sarma	NULL
,	NULL
V.	NULL
,	NULL
Dixit	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
1421-1427	NULL
38	NULL
.	NULL

Takeuchi	NULL
,	NULL
M.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
19935-19942	NULL
39	NULL
.	NULL

Kuhns	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Long	NULL
Priel	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Gallin	NULL
,	NULL
J.	NULL
I	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
3959-3964	NULL
H	NULL
i	NULL
>	NULL
Co	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
Bacterial	NULL
Lipopolysaccharide	NULL
Activates	NULL
Nuclear	NULL
Factor-KB	NULL
through	NULL
Interleukin-1	NULL
Signaling	NULL
Mediators	NULL
in	NULL
Cultured	NULL
Human	NULL
Dermal	NULL
Endothelial	NULL
Cells	NULL
and	NULL
Mononuclear	NULL
Phagocytes	NULL
Frank	NULL
X.	NULL
Zhang	NULL
,	NULL
Carsten	NULL
J.	NULL
Kirschning	NULL
,	NULL
Roberta	NULL
Mancinelli	NULL
,	NULL
Xiao-Ping	NULL
Xu	NULL
,	NULL
Yiping	NULL
Jin	NULL
,	NULL
Emmanuelle	NULL
Faure	NULL
,	NULL
Alberto	NULL
Mantovani	NULL
,	NULL
Mike	NULL
Rothe	NULL
,	NULL
Marta	NULL
Muzio	NULL
and	NULL
Moshe	NULL
Arditi	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:7611-7614.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.12.7611	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
//www.jbe.org/content/274/12/7611	NULL
Alerts	NULL
:	NULL
*When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
*	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
39	NULL
references	NULL
,	NULL
25	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www.jbe.org/content/274/12/7611	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL

